323990 — VaxCell Biotherapeutics Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for VaxCell Biotherapeutics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	18,903	27,309	20,392	50,046	35,509
Net Total Accounts Receivable
Net Total Receivables	112	374	291	715	2,257
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	19,186	28,197	20,898	51,227	39,105
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,142	2,804	2,541	2,674	6,509
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	35,498	31,276	24,163	84,980	76,944
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	594	392	307	924	2,820
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	830	1,196	836	1,487	4,950
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Total Equity	34,667	30,080	23,327	83,493	71,994
Total Liabilities & Shareholders' Equity	35,498	31,276	24,163	84,980	76,944
Total Common Shares Outstanding